Hemorrhoid Treatment Devices Market: Market Size & Forecast 2026

The market covers a range of devices used in the diagnosis and treatment of hemorrhoids, from rubber band ligators and sclerotherapy instruments to Doppler-guided ligation systems and energy-based ablation tools. These devices are used across hospitals, ambulatory surgical centers, and physician offices, with the ambulatory segment growing particularly rapidly as outpatient procedures become more common. The market spans North America, Europe, Asia-Pacific, and other regions, with varying adoption rates based on healthcare infrastructure and disease prevalence.

• •Includes rubber band ligators, cryotherapy devices, Doppler-guided hemorrhoid artery ligation systems, and energy-based ablation instruments
• •Serves hospital, ambulatory surgical center, and clinic-based care settings
• •Ranges in market size estimates from approximately $795 million to over $1 billion depending on scope and source definitions

The rising global prevalence of hemorrhoids, exacerbated by aging populations, sedentary lifestyles, and increasing rates of obesity, is expanding the addressable patient population. Growing preference for minimally invasive procedures over traditional surgical excision is accelerating adoption of advanced device-based treatments. Rising healthcare spending and improving access to modern gastroenterology and colorectal services in emerging markets are further propelling market growth.

• •Aging populations in developed nations combined with rising obesity and sedentary lifestyle trends are increasing disease incidence
• •Minimally invasive device-based treatments offer faster recovery times and lower complication rates compared to surgical options
• •Expanding healthcare infrastructure and growing ambulatory surgery utilization in emerging markets

The market is commonly segmented by product type, including band ligation devices, cryotherapy systems, infrared coagulation devices, and Doppler-guided hemorrhoid artery ligation systems. By end-user, the market includes hospitals, ambulatory surgical centers, and specialty clinics. Geographically, North America currently leads in market share due to advanced healthcare infrastructure and high disease awareness, while the Asia-Pacific region is expected to grow at the fastest pace driven by large patient populations and improving medical access.

• •Product segments include band ligators, cryotherapy devices, infrared coagulation systems, and Doppler-guided artery ligation devices
• •End-users span hospitals, ambulatory surgical centers, and gastroenterology or colorectal clinics
• •North America dominates current market share, with Asia-Pacific emerging as the fastest-growing regional market

What are the recent trends and outlook?

The market is moving toward greater adoption of energy-based and Doppler-guided technologies that reduce procedural discomfort and improve clinical outcomes. Ambulatory surgery centers are becoming increasingly important distribution channels as outpatient hemorrhoid procedures gain acceptance. Over the coming decade, continued innovation in minimally invasive technologies, expanding access in emerging markets, and growing patient preference for non-surgical options are expected to sustain solid market growth.

• •Energy-based and Doppler-guided devices are gaining share over traditional treatment approaches
• •Expansion of ambulatory surgery centers is creating new access points for outpatient hemorrhoid procedures
• •Patient preference for non-surgical and office-based treatments continues to drive device innovation and adoption